Evidence map›Paper›PMID 37509132›Full record

ArticleBiomolecules2023

Potential Neuroprotective Effects of Dietary Omega-3 Fatty Acids on Stress in Alzheimer's Disease.

Kaitlyn B Hartnett, Bradley J Ferguson, Patrick M Hecht, Luke E Schuster, Joel I Shenker, David R Mehr, Kevin L Fritsche, Martha A Belury, Douglas W Scharre, Adam J Horwitz and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Flaxseed Oil (Nutrients · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Kaitlyn B HartnettSchool of Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA.
Bradley J FergusonInterdisciplinary Neuroscience Program, University of Missouri-Columbia, Columbia, MO 65212, USA.ORCID 0000-0002-1636-7849
Patrick M HechtInterdisciplinary Neuroscience Program, University of Missouri-Columbia, Columbia, MO 65212, USA.
Luke E SchusterSchool of Medicine, University of Kansas, Kansas City, KS 66160, USA.
Joel I ShenkerDepartment of Neurology, University of Missouri-Columbia, Columbia, MO 65212, USA.
David R MehrFamily & Community Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA.
Kevin L FritscheDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65211, USA.
Martha A BeluryDepartment of Human Sciences, Ohio State University, Columbus, OH 43210, USA.
Douglas W ScharreDepartment of Neurology, Ohio State University, Columbus, OH 43210, USA.
Adam J HorwitzStrock Medical Group, Boulder, CO 80303, USA.
Briana M KilleChildren's Hospital Colorado, Aurora, CO 80045, USA.
Briann E SuttonCollege of Osteopathic Medicine, William Carey University, Hattiesburg, MS 39401, USA.
Paul E TatumDivision of Palliative Medicine; Washington University. St. Louis, MO 63110, USA.
C Michael GreenliefDepartment of Chemistry, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0001-6420-7375
David Q BeversdorfInterdisciplinary Neuroscience Program, University of Missouri-Columbia, Columbia, MO 65212, USA.ORCID 0000-0002-0298-0634
University of Missouri · USThe Ohio State University · USChildren's Hospital Colorado · USUniversity of Colorado Boulder · USUniversity of Kansas · USUniversity of Missouri Health System · USWashington University in St. Louis · USWilliam Carey University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA large number of individual potentially modifiable factors are associated with risk for Alzheimer's disease (AD). However, less is known about the interactions between the individual factors.

methodsIn order to begin to examine the relationship between a pair of factors, we performed a pilot study, surveying patients with AD and controls for stress exposure and dietary omega-3 fatty acid intake to explore their relationship for risk of AD.

resultsFor individuals with the greatest stress exposure, omega-3 fatty acid intake was significantly greater in healthy controls than in AD patients. There was no difference among those with low stress exposure.

conclusionsThese initial results begin to suggest that omega-3 fatty acids may mitigate AD risk in the setting of greater stress exposure. This will need to be examined with larger populations and other pairs of risk factors to better understand these important relationships. Examining how individual risk factors interact will ultimately be important for learning how to optimally decrease the risk of AD.

Indexed as

Alzheimer DiseaseFatty Acids, Omega-3Neuroprotective AgentsDietFatty AcidsHumansPilot ProjectsFatty AcidsFatty Acids, Omega-3Neuroprotective AgentsAlzheimer’s diseaseomega-3 fatty acidsstress

Identifiers

PMID37509132
PMCPMC10377362
OpenAlexW4383724348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.